Irene Aini

Irene Aini

Auto-generated profile, based on publicly available information

Irene Aini

Endocrinology Unit, Azienda Ospedaliera Universitaria Sassari, Sassari, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
RRRosaria Ruggeri
Rosaria Ruggeri
IAIrene Aini
Irene Aini
SGStefano Gay
Stefano Gay
EGErika Maria Grossrubatscher
Erika Maria Grossrubatscher
CMCamilla Mancini
Camilla Mancini
NGNIKE group
NIKE group

6 September 2025 in Journal of Endocrinological Investigation
Verified
Journal Article
Open access
PDF file
BABarbara Altieri
Barbara Altieri
IAIrene Aini
Irene Aini
GCGiuseppe Cannavale
Giuseppe Cannavale
CMCamilla Mancini
Camilla Mancini
CMCamilla Mancini
Camilla Mancini
APAlessandro Peri
Alessandro Peri
Exercise associated hyponatremia (EAH) is a medical condition that can occur during physical exertion. Initially, EAH was considered to be restricted to extreme endurance activities, such as ultramarathons and Ironman triathlons. However, it has been more recently recognized in a variety of sports, including team sports and in shorter-duration events. The pathophysiology of EAH is multifactorial and includes excessive fluid intake and non-osmotic arginine vasopressin secretion, which is induced by physical activity. Sodium loss through sweat appears to play a less important role in contributing to EAH. The clinical presentation may vary, depending on the degree of serum sodium reduction. Symptoms, which are due to increased intracranial pressure, may vary from nausea, vomiting, headache, confusion to severe alterations in cognitive functions, decorticate posturing, respiratory distress, coma and even death. It is of pivotal importance to differentiate EAH from other conditions that may present with similar signs/symptoms, such as for instance hypoglycemia, orthostatic hypotension, vasovagal syncope, heat stroke. The treatment of EAH depends on the severity of symptoms. In life-threatening situations intravenous infusion of hypertonic saline solution (3%NaCl) is recommended. In less severe situations oral hypertonic saline solutions can be administered, as an alternative to intravenous hypertonic saline, when tolerated by patients. When symptoms are negligible, the treatment can be limited to fluid restriction. Effective strategies to prevent EAH would be important to reduce the risk of incurring in potentially life-threatening situations. In particular, recommendations to drink in anticipation of thirst during physical exertions should be replaced by the “drinking when thirsty” strategy.

21 June 2025 in Journal of Neuroendocrinology
Verified
Journal Article
Open access
TFTiziana Feola
Tiziana Feola
ACAlessia Cozzolino
Alessia Cozzolino
FGFederica Grillo
Federica Grillo
MBMaria Francesca Birtolo
Maria Francesca Birtolo
IAIrene Aini
Irene Aini
EGElisa Giannetta
Elisa Giannetta
Background: Neuroendocrine neoplasms (NENs) may metastasize very rarely to the thyroid. The current paper aims at identifying peculiar thyroid nodule's features that could prompt their diagnosis and analyzing therapeutic approach and patient's outcome. Materials and Methods: A case series of three patients have been collected from three Italian referral centers. Moreover, we performed a keyword based PUBMED search, using relevant keywords. Results: We included in the review 27 papers and 33 cases have been identified. Patients’ age ranged from 17 to 85 years (mean age: 55.8 ± 14.2 years), 14 males, 42.4%. The majority of cases (48.5%) originated from a thoracic NEN. Median time to diagnosis from the primary tumor was 48 months (range 1–252 months). At ultrasound, they were generally hypoechoic nodules with irregular margins. The diagnosis was made by fine‐niddle aspiration in the majority of cases, followed by nuclear medicine imaging. At immunohistochemistry, chromogranin A and synaptophysin were expressed in almost all of them, with negative calcitonin and thyroid transcription factor‐1. Surgery or systemic treatment were needed according to primary tumor, disease stage, and patients’ general condition. Prognosis was variable, better if primary tumor origin was thoracic. Conclusions: Thyroid metastases from NENs should be considered in the diagnostic work‐up of suspicious thyroid nodules in patients with a positive medical history of previous NEN, mainly of thoracic origin. Immunohistochemistry is the key diagnostic tool for their identification. A prompt and correct diagnosis is mandatory because of its crucial prognostic and therapeutic implications.